Mortality among persons with a history of Kawasaki disease in Japan: Can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae?

• Published in: Acta Paediatrica Vol. 94; no. 4; pp. 429 - 434
• Main Authors: Nakamura, Yosikazu, Aso, Eiko, Yashiro, Mayumi, Uehara, Ritei, Watanabe, Makoto, Tajimi, Morihiro, Oki, Izumi, Ojima, Toshiyuki, Yanagawa, Hiroshi, Kawasaki, Tomisaku
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.04.2005; Blackwell
• Subjects: Biological and medical sciences; Child; Child, Preschool; Female; follow-up; Follow-Up Studies; General aspects; Heart Diseases - complications; Humans; Infant; Infant, Newborn; Japan - epidemiology; long-term prognosis; Male; Medical sciences; mortality rate; Mucocutaneous lymph node syndrome; Mucocutaneous Lymph Node Syndrome - complications; Mucocutaneous Lymph Node Syndrome - mortality; Prognosis; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Sex Factors; Asia; Japan; Kawasaki syndrome; Pediatrics; Prognosis; Cardiovascular disease; Autoimmune disease; History; Epidemiology; Case history; Vascular disease; follow-up; Vasculitis; long-term prognosis; Heart disease; Systemic disease; Child; Human; Interruption; Mortality; Rate; Sequela; Long term; mortality rate; Surveillance; Follow up study; Mucocutaneous lymph node syndrome
• ISSN: 0803-5253; 1651-2227
• DOI: 10.1111/j.1651-2227.2005.tb01913.x

Aim: To clarify the question of whether patients with Kawasaki disease suffer a higher mortality rate after the incidence of the disease in comparison with age‐matched healthy individuals. Methods: Between July 1982 and December 1992, 52 collaborating hospitals collected data on all patients having a new, definite diagnosis of Kawasaki disease. Patients were followed up until 31 December 2001 or their death. The expected number of deaths was calculated from Japanese vital statistics data and compared with the observed number. Results: Of 6576 patients enrolled, 29 (20 males and 9 females) died. The standardized mortality ratio (SMR: the observed number of deaths divided by the expected number of deaths based on the vital statistics in Japan) was 1.15 (95% CI: 0.77–1.66). In spite of the high SMRs during the acute phase, the mortality rate was not high after the acute phase for the entire group of patients. Although the SMR after the acute phase was 0.75 for those without cardiac sequelae, six males (but none of the females) with cardiac sequelae died during this period; and the SMR for the male group with cardiac sequelae was 1.95 (95% CI: 0.71–4.25). The mortality from congenital anomalies of the circulatory system was elevated, but no increase in cancer deaths was observed. Conclusion: Although it was not statistically significant, the mortality rate among males with cardiac sequelae due to Kawasaki disease appeared to be higher than in the general population. On the other hand, the mortality rates for females with the sequelae and both males and females without sequelae were not elevated.